Mast cells have been shown to induce tumor endothelial proliferation by the release of Vascular Endothelial Growth Factor (VEGF) in response to the hypoxic environment in the tumor [10], which may be translatable to muscles in PAD patients, in which hypoxia occurs as well [11,12]. The gene discussed is VEGFA; the disease is peripheral arterial disease.